1. Stocks
  2. Corvus Pharmaceuticals Inc
  3. Swot
swot-logo

Corvus Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Corvus Pharmaceuticals Inc has 15 Strengths, 11 Weaknesses, 6 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Consistent Highest Return Stocks over Five Years - Nifty500

Significant (over 30%) distance from 52 week high

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over 1 Year

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Company with Low Debt

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Top Gainers

Stock with Low PE (PE < = 10)

Volume Shockers

Biggest Price Gainers from Open

Highest Recovery from 52 Week Low

Stocks with Quarter Change % less than Industry

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Highest fall from 52 Week High

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Stocks Underperforming their Industry Price Change in the Quarter

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts

Mutual Funds Increased Shareholding in Past Month

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months